Zepp Health (NYSE:ZEPP) PT Set at $5.19 by Fundamental Research

Zepp Health (NYSE:ZEPPGet Free Report) has been given a $5.19 target price by research analysts at Fundamental Research in a report issued on Tuesday, BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock.

Zepp Health Stock Down 3.6 %

ZEPP stock opened at $0.74 on Tuesday. Zepp Health has a fifty-two week low of $0.72 and a fifty-two week high of $2.10. The stock has a fifty day moving average of $0.89 and a 200-day moving average of $1.19. The company has a market capitalization of $44.56 million, a price-to-earnings ratio of -1.85 and a beta of 0.88. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.26 and a current ratio of 1.71.

Zepp Health (NYSE:ZEPPGet Free Report) last issued its earnings results on Monday, March 18th. The company reported ($0.02) earnings per share for the quarter. The business had revenue of $84.47 million for the quarter. Zepp Health had a negative return on equity of 7.24% and a negative net margin of 8.45%.

Zepp Health Company Profile

(Get Free Report)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

Recommended Stories

Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.